Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

526
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
526
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

525
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
525
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

701
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
701
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

375
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
375
Survival Curves01:18

Survival Curves

611
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
611
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

969
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
969

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimal design of dynamic experiments for scalar-on-function linear models with application to a biopharmaceutical study.

Biometrics·2026
Same author

Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Wire Cerclage Versus Rigid Plate Fixation: A Retrospective Cohort Study and Cost-Benefit Analysis on Method of Sternotomy Closure After Cardiac Surgery.

Heart, lung & circulation·2025
Same author

Platform trials: key features, when to use them and methodological challenges.

The Medical journal of Australia·2025
Same author

Making Sense of Hierarchical Composite End Points in Randomized Clinical Trials-A Primer for Infectious Diseases Clinicians and Researchers.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Prevalence of Intolerance to Amines and Salicylates in Individuals with Atopic Dermatitis: A Systematic Review and Meta-Analysis.

Nutrients·2025
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
Same journal

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same journal

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same journal

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Statistics in medicine·2026
Same journal

Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging-Enhanced Adaptive Sampling.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

An Approach to Design Adaptive Clinical Trials With Time-to-Event Outcomes Based on a General Bayesian Posterior

James M McGree1, Antony M Overstall2, Mark Jones3

  • 1School of Mathematical Sciences, Queensland University of Technology, Brisbane, Australia.

Statistics in Medicine
|October 9, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new method for designing adaptive clinical trials for time-to-event outcomes. This approach enhances efficiency and ethics by not requiring a predefined data-generating process, improving trial reliability.

Keywords:
Bayesian designadaptive designpartial likelihoodproportional hazardsrobust inferencesequential design

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Related Experiment Videos

Last Updated: Jan 6, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Area of Science:

  • Clinical Research
  • Biostatistics
  • Medical Informatics

Background:

  • Adaptive clinical trials offer ethical and efficiency advantages over standard designs.
  • Current adaptive trial design relies on simulations with potentially misspecified data-generating processes.
  • Misspecification can lead to suboptimal trial performance, impacting statistical power and error rates.

Purpose of the Study:

  • To propose a novel approach for designing adaptive clinical trials with time-to-event outcomes.
  • To develop a method that avoids explicit definition of the data-generating process.
  • To enhance the robustness and reliability of adaptive trial designs.

Main Methods:

  • Utilized a general Bayesian framework for trial design.
  • Employed partial likelihood for robust inference on treatment effects.
  • Designed adaptive trials with implicitly defined data-generating processes.

Main Results:

  • Demonstrated the benefits of the proposed approach through an illustrative example.
  • Successfully redesigned a motivating clinical trial using the new methodology.
  • Showcased robustness to the baseline hazard function's form.

Conclusions:

  • The proposed Bayesian approach facilitates adaptive clinical trial design for time-to-event outcomes without explicit data-generating process assumptions.
  • This method improves robustness and efficiency in adaptive trial design.
  • The approach is applicable to real-world clinical trial scenarios, including vaccine trials.